BRAF and differentiated thyroid carcinoma: reported that BRAF inhibitors enhanced radiosensitivity in BRAF V600E mutant glioma (63), possibly through disruption of BRAF-mediated upregulation of non-homologous end joining (NHEJ) machinery as seen in radio-resistant papillary thyroid carcinoma (64).